drugset / Trial / NCT01388088

The Effect of Amiloride and Spironolactone in Patients With Hypertension

NCT01388088

Phase 4 Completed 23 enrolled Erling Bjerregaard Pedersen
RandomizedCrossoverDouble-blindTreatment

Summary

The investigators wish to investigate the potential effects of potassium. In this study we will examine patients with hypertension and increase their potassium-levels using Amiloride and Spironolactone. The investigators will examine the changes in the cardiovascular system using a Sphygmocor-scanner.

Timeline

Start
2010-09
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiloride Small molecule 5 mg
Comparator Spironolactone Small molecule 25 mg

Indications